Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
Radiology: Imaging Cancer · 2025
DOI: 10.1148/rycan.250034 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Ran Wei und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National High-Level Hospital Clinical Research.
Abstract (Originalsprache)
The CatBoost machine learning model accurately predicted advanced-stage progression of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization (TACE) and identified patients who benefited from post-TACE systemic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Radiation Oncology, Cancer Center, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road, Guangzhou, China 510080.
- Department of Sonography, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences and Peking Union Medical College, Bei…
- Department of Minimal Invasive Intervention, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
- Department of Interventional Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Ran Wei, Zelong Liu, Lingjie Ju, Mengxuan Zuo, Wang Yao, Wang Li, Peihong Wu, Chao An, Zhenwei Peng
Förderung
- National High-Level Hospital Clinical Research
Zitieren
APA
Wei, R., Liu, Z., Ju, L., Zuo, M., Yao, W., Li, W., Fu, Y., Liu, W., Li, C., Wu, P., Han, J., Zhang, Y., Tu, J., Ren, J., An, C., & Peng, Z. (2025). Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.250034
Vancouver
Wei R, Liu Z, Ju L, Zuo M, Yao W, Li W, et al. Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.250034
BibTeX
@article{Wei2025,
author = {Wei, Ran and Liu, Zelong and Ju, Lingjie and Zuo, Mengxuan and Yao, Wang and Li, Wang and Fu, Yan and Liu, Wendao and Li, Chengzhi and Wu, Peihong and Han, Jianjun and Zhang, Yaojun and Tu, Jianfei and Ren, Junhong and An, Chao and Peng, Zhenwei},
title = {Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization},
journal = {Radiology: Imaging Cancer},
year = {2025},
doi = {10.1148/rycan.250034}
}
EUVIMED